| The support of human genetic evidence for approved drug indications MR Nelson, H Tipney, JL Painter, J Shen, P Nicoletti, Y Shen, A Floratos, ... Nature genetics 47 (8), 856-860, 2015 | 1135 | 2015 |
| Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases SJ Reisinger, PB Ryan, DJ O'Hara, GE Powell, JL Painter, EN Pattishall, ... Journal of the American Medical Informatics Association 17 (6), 652-662, 2010 | 108 | 2010 |
| Social media listening for routine post-marketing safety surveillance GE Powell, HA Seifert, T Reblin, PJ Burstein, J Blowers, JA Menius, ... Drug safety 39, 443-454, 2016 | 94 | 2016 |
| Using social listening data to monitor misuse and nonmedical use of bupropion: a content analysis LS Anderson, HG Bell, M Gilbert, JE Davidson, C Winter, MJ Barratt, ... JMIR Public Health and Surveillance 3 (1), e6174, 2017 | 47 | 2017 |
| Performance of stratified and subgrouped disproportionality analyses in spontaneous databases S Seabroke, G Candore, K Juhlin, N Quarcoo, A Wisniewski, R Arani, ... Drug safety 39, 355-364, 2016 | 46 | 2016 |
| Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review B Kompa, JB Hakim, A Palepu, KG Kompa, M Smith, PA Bain, ... Drug Safety 45 (5), 477-491, 2022 | 15 | 2022 |
| A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data D Parks, X Lin, JL Painter, J Cheng, CM Hunt, CF Spraggs, JJ Nelson, ... Pharmacoepidemiology and drug safety 22 (6), 571-578, 2013 | 14 | 2013 |
| Validation of multivariate outlier detection analyses used to identify potential drug-induced liver injury in clinical trial populations X Lin, D Parks, J Painter, CM Hunt, HA Stirnadel-Farrant, J Cheng, ... Drug safety 35, 865-875, 2012 | 14 | 2012 |
| Construction and annotation of a UMLS/SNOMED-based drug ontology for observational pharmacovigilance GH Merrill, PB Ryan, JL Painter Methods, 2008 | 13 | 2008 |
| Developing crowdsourced training data sets for pharmacovigilance intelligent automation A Gartland, A Bate, JL Painter, TA Casperson, GE Powell Drug Safety 44, 373-382, 2021 | 9 | 2021 |
| Strategies for distributed curation of social media data for safety and pharmacovigilance TA Casperson, JL Painter, J Dietrich Proceedings of the International Conference on Data Science (ICDATA), 118, 2016 | 9 | 2016 |
| Electronically predicting corrective options based on a sensed physiological characteristic T Trygstad, A Menius, JL Painter US Patent App. 14/824,730, 2016 | 7 | 2016 |
| Correction to: Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review B Kompa, JB Hakim, A Palepu, KG Kompa, M Smith, PA Bain, ... Drug Safety 46 (4), 433-433, 2023 | 5 | 2023 |
| Predicting breast cancer chemotherapeutic response using a novel tool for microarray data analysis J Cheng, J Greshock, J Painter, X Lin, K Lee, S Zheng, A Menius Journal of Integrative Bioinformatics 9 (2), 80-87, 2012 | 5 | 2012 |
| Toward automating an inference model on unstructured terminologies: Oxmis case study JL Painter Advances in Computational Biology, 645-651, 2010 | 4 | 2010 |
| Codeslinger: An interactive biomedical ontology browser JL Painter, NL Flowers Conference on Artificial Intelligence in Medicine in Europe, 260-264, 2009 | 4 | 2009 |
| Inter-translation of Biomedical Coding Schemes Using UMLS. JL Painter, KM Kleiner, GH Merrill AAAI Fall Symposium: Semantic Web for Collaborative Knowledge Acquisition …, 2006 | 4 | 2006 |
| An adaptive feature selection method for microarray data analysis J Cheng, J Greshock, L Shi, J Painter, X Lin, K Lee, S Zheng, R Wooster, ... 2012 IEEE International Conference on Bioinformatics and Biomedicine, 1-6, 2012 | 3 | 2012 |
| Using SNOMED to normalize and aggregate drug references in the Safetyworks observational pharmacovigilance project GH Merrill, PB Ryan, JL Painter KR-MED 2008, 126, 2008 | 3 | 2008 |
| Engaging Patients via Online Healthcare Fora: Three Pharmacovigilance Use Cases G Powell, V Kara, JL Painter, L Schifano, E Merico, A Bate Frontiers in Pharmacology 13, 2022 | 2 | 2022 |
Matthew R NelsonDeerfield Management在 deerfield.com 的电子邮件经过验证
